Free Trial

NeuroOne Medical Technologies Q3 2024 Earnings Report

NeuroOne Medical Technologies logo
$0.86 +0.01 (+1.39%)
As of 12:01 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NeuroOne Medical Technologies EPS Results

Actual EPS
-$0.10
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NeuroOne Medical Technologies Revenue Results

Actual Revenue
$0.83 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NeuroOne Medical Technologies Announcement Details

Quarter
Q3 2024
Time
N/A
Remove Ads

NeuroOne Medical Technologies Earnings Headlines

Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More NeuroOne Medical Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NeuroOne Medical Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NeuroOne Medical Technologies and other key companies, straight to your email.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies (NASDAQ:NMTC), a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

View NeuroOne Medical Technologies Profile

More Earnings Resources from MarketBeat